跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
None - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
None
Approved
STANDARD
None
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bf5873f684a5d7e1
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
bf5873f684a5d7e1
Drug Approval Philippines Name
None
Product Name
None
Registration Number
DRP-6997-01
Brand Name
None
Generic Name
Gliclazide
Dosage Form
Modified-Release Tablet
Dosage Strength
30 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Westfield Pharmaceutical, Inc.
Distributor
Watsons Personal Care Stores (Philippines), Inc.
Issuance Date
29 December 2023
Expiry Date
28 February 2029
Pharmacologic Category
Oral Hypoglycemic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bf5873f684a5d7e1
Type
Standard
Back to Philippines FDA Approvals